...
首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis and enzyme-based evaluation of analogues L -tyrosine thiol carboxylic acid inhibitor of metallo-β-lactamase IMP-1
【24h】

Synthesis and enzyme-based evaluation of analogues L -tyrosine thiol carboxylic acid inhibitor of metallo-β-lactamase IMP-1

机译:金属-β-内酰胺酶IMP-1的类似物L-酪氨酸硫醇羧酸抑制剂的合成和基于酶的评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The emergence of drug-resistant pathogenic bacteria is occurring due to the global overuse and misuse of β-lactam antibiotics. Infections caused by some bacteria which secrete metallo-β-lactamases (enzymes that inactivate β-lactam antibiotics) are increasingly prevalent and have become a major worldwide threat to human health. These bacteria are resistant to β-lactam antibiotics and MBL-inhibitor/β-lactam antibiotic combination therapy can be a strategy to overcome this problem. So far, no clinically available inhibitors of metallo-β-lactamases (MBLs) have been reported. In this study, L-benzyl tyrosine thiol carboxylic acid analogues (2a-2k) were synthesized after the study of computational simulation by adding of methyl, chloro, bromo and nitro groups to the benzyl ring for investigation of SAR analysis. Although the synthesized molecules 2a-k shows the potent inhibitory effects against metallo-β-lactamase (IMP-1) with the range of Kic values of 1.04-4.77?μM, they are not as potent as the candidate inhibitor.
机译:由于全球过度使用和滥用β-内酰胺类抗生素,导致了耐药性病原菌的出现。由某些分泌金属β-内酰胺酶(使β-内酰胺抗生素失活的酶)的细菌引起的感染日益普遍,已成为全世界范围内对人类健康的主要威胁。这些细菌对β-内酰胺类抗生素具有抗性,而MBL-抑制剂/β-内酰胺类抗生素联合治疗可以解决这一问题。迄今为止,尚未报道金属β-内酰胺酶(MBLs)的临床可用抑制剂。在这项研究中,L-苄基酪氨酸硫醇羧酸类似物(2a-2k)是在计算模拟研究之后通过向苄基环中添加甲基,氯,溴和硝基基团而合成的,用于合成孔径雷达分析。尽管合成的分子2a-k在Kic值为1.04-4.77?μM的范围内显示出对金属β-内酰胺酶(IMP-1)的有效抑制作用,但它们不如候选抑制剂有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号